Bayer may be suffering from buyer's remorse after buying Monsanto, the maker of Roundup, last year. A California jury has awarded $289 million dollars to a groundskeeper who blames Roundup for causing his cancer. Bayer's stock dropped 10 percent after the verdict. What's next for the weedkiller maker? In this podcast, Marketplace reports that Bayer will likely face increasing legal costs as well as possible consumer backlash.